Slowing Parkinson’s by Blocking a Key Protein

AI Summary

Recent research suggests that monoclonal antibodies may offer a breakthrough in slowing the progression of Parkinson's disease by blocking a key protein. This advance could have significant implications for treatment strategies.

Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's disease (PD). This ...